106 results on '"Davies, Kay E."'
Search Results
2. Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy
3. Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy
4. Alterations of neuromuscular junctions in Duchenne muscular dystrophy
5. Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model
6. Limitations to adaptive homeostasis in an hyperoxia-induced model of accelerated ageing
7. Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy
8. Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
9. Pharmacological advances for treatment in Duchenne muscular dystrophy
10. The Evolutionarily Conserved Tre2/Bub2/Cdc16 (TBC), Lysin Motif (LysM), Domain Catalytic (TLDc) Domain Is Neuroprotective against Oxidative Stress
11. Circadian profiling in two mouse models of lysosomal storage disorders; Niemann Pick type-C and Sandhoff disease
12. A Novel Mouse Model of a Patient Mucolipidosis II Mutation Recapitulates Disease Pathology
13. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice
14. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse
15. Engineering Multiple U7snRNA Constructs to Induce Single and Multiexon-skipping for Duchenne Muscular Dystrophy
16. The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery
17. Corrigendum to “Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene” Neuromuscular Disorders 39 (2024) 5–9
18. Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene
19. Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping
20. Syncoilin isoform organization and differential expression in murine striated muscle
21. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model
22. Is Good Housekeeping the Key to Motor Neuron Survival?
23. Microarray analysis of mdx mice expressing high levels of utrophin: Therapeutic implications for dystrophin deficiency
24. Generation and Characterization of Transgenic Mice with the Full-length Human DMD Gene
25. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: An MRI and MRS study
26. Mutations in α-Tubulin Cause Abnormal Neuronal Migration in Mice and Lissencephaly in Humans
27. Intermediate filament-like protein syncoilin in normal and myopathic striated muscle
28. The allure of stem cell therapy for muscular dystrophy
29. Behavioural characterisation of the robotic mouse mutant
30. High-Throughput Analysis of Promoter Occupancy Reveals Direct Neural Targets of FOXP2, a Gene Mutated in Speech and Language Disorders
31. Chapter 7 Spinal muscular atrophies and hereditary motor neuropathies
32. Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18)
33. Identification and Characterization of Murine SCARA5, a Novel Class A Scavenger Receptor That Is Expressed by Populations of Epithelial Cells
34. Treating Muscular Dystrophy with Stem Cells?
35. Isolation and culture of motor neurons from the newborn mouse spinal cord
36. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit
37. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration
38. Spinal muscular atrophy at the crossroads of basic science and therapy
39. Ets, Ap-1 and GATA factor families regulate the utrophin B promoter: potential regulatory mechanisms for endothelial-specific expression
40. Syncoilin accumulation in two patients with desmin-related myopathy
41. Chapter 16 Spinal Muscular Atrophy
42. A- and B-utrophin Have Different Expression Patterns and Are Differentially Up-regulated in mdx Muscle
43. Association of Syncoilin and Desmin: LINKING INTERMEDIATE FILAMENT PROTEINS TO THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX
44. Identification of a New Pmp22 Mouse Mutant and Trafficking Analysis of a Pmp22 Allelic Series Suggesting That Protein Aggregates May Be Protective in Pmp22-Associated Peripheral Neuropathy
45. The role of utrophin in the potential therapy of Duchenne muscular dystrophy
46. Muscular Dystrophy—Reason for Optimism?
47. Syncoilin, a Novel Member of the Intermediate Filament Superfamily That Interacts with α-Dystrobrevin in Skeletal Muscle
48. A Novel Mechanism for Modulating Synaptic Gene Expression: Differential Localization of α-Dystrobrevin Transcripts in Skeletal Muscle
49. Non-toxic ubiquitous over-expression of utrophin in the mdx mouse
50. Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin–dystrophin knockout mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.